# Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects

> **NCT03939429** · PHASE1 · COMPLETED · sponsor: **Qpex Biopharma, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Bacterial Infections

## Interventions

- **DRUG:** QPX2015
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03939429
- **Lead sponsor:** Qpex Biopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-20
- **Primary completion:** 2019-10-06
- **Final completion:** 2019-10-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03939429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03939429, "Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03939429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*